Loading data for PRPO — first visit, this takes a few seconds.
Precipio, Inc. (PRPO)
NasdaqCM: PRPO
· 实时价格 · USD
27.32
+0.41 (1.52%)
收盘价： Sep 11, 2026, 3:59 PM
27.32
+0.00%
盘后: 7:30 PM
股价、关键数字和最新消息，都在这一页。
Precipio, Inc.（PRPO）股价、分析与数据
1.52% (1D)
| 买价 | 23.68 |
| 市值 | 48.9M |
| 营收（TTM） | 27.2M |
| 净利润（TTM） | -1.22M |
| 1.33 | |
| -0.62 | |
| n/a | |
| 70.05 | |
| 市净率（TTM） | 3.31 |
| 市销率（TTM） | 1.80 |
| 财报日期 | n/a |
| 卖价 | 31.35 |
| 成交量 | 89,108 |
| 20日均量 | 115,550 |
| 开盘价 | 27.25 |
| 前收盘价 | 26.91 |
| 日内区间 | 26.25 - 27.98 |
| 52周区间 | 16.00 - 33.63 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 PRPO
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-ph...
公司完整简介财报意外
Precipio 已于 Nov 13, 2023 发布季度财报：
- 营收为 $7.02M 低于预期 $0, ， 24.18% 同比增长.
- 每股收益为 -1.04 超出预期 0.36, ， 62.86% 同比增长.
第 1 页，共 2 页